Global Media Coverage of the Benefits and Harms of Early Detection Tests

Mary O'Keeffe; Alexandra Barratt; Alice Fabbri; Joshua R Zadro; Giovanni E Ferreira; Sweekriti Sharma; Ray N Moynihan

doi:10.1001/jamainternmed.2021.0261

Global Media Coverage of the Benefits and Harms of Early Detection Tests

Mary O'Keeffe
, Alexandra Barratt
, Alice Fabbri
, Joshua R Zadro
, Giovanni E Ferreira
, Sweekriti Sharma
, Ray N Moynihan

Institute for Evidence-Based Healthcare

Research output: Contribution to journal › Letter › Research › peer-review

16 Citations (Scopus)

Abstract

Innovations in technologies for early detection of diseases, such as breast cancer, dementia, and atrial fibrillation, are gaining increasing attention. The media is a key avenue through which tests are promoted to asymptomatic individuals, and it could have an important role in encouraging realistic expectations of the benefits and harms of early detection, including unnecessary diagnoses. Evidence suggests that medical media coverage tends to overplay benefits, downplay harms, and ignore conflicts of interest, but there are few data on coverage of early detection tests.

Original language	English
Article number	0261
Pages (from-to)	865-867
Number of pages	3
Journal	JAMA Internal Medicine
Volume	181
Issue number	6
Early online date	5 Apr 2021
DOIs	https://doi.org/10.1001/jamainternmed.2021.0261
Publication status	Published - Jun 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1001/jamainternmed.2021.0261

Cite this

@article{2c9d0f43f089473e9a993746701f8fc6,

title = "Global Media Coverage of the Benefits and Harms of Early Detection Tests",

abstract = "Innovations in technologies for early detection of diseases, such as breast cancer, dementia, and atrial fibrillation, are gaining increasing attention. The media is a key avenue through which tests are promoted to asymptomatic individuals, and it could have an important role in encouraging realistic expectations of the benefits and harms of early detection, including unnecessary diagnoses. Evidence suggests that medical media coverage tends to overplay benefits, downplay harms, and ignore conflicts of interest, but there are few data on coverage of early detection tests.",

author = "Mary O'Keeffe and Alexandra Barratt and Alice Fabbri and Zadro, \{Joshua R\} and Ferreira, \{Giovanni E\} and Sweekriti Sharma and Moynihan, \{Ray N\}",

year = "2021",

month = jun,

doi = "10.1001/jamainternmed.2021.0261",

language = "English",

volume = "181",

pages = "865--867",

journal = "JAMA Internal Medicine",

issn = "2168-6106",

publisher = "American Medical Association",

number = "6",

}

TY - JOUR

T1 - Global Media Coverage of the Benefits and Harms of Early Detection Tests

AU - O'Keeffe, Mary

AU - Barratt, Alexandra

AU - Fabbri, Alice

AU - Zadro, Joshua R

AU - Ferreira, Giovanni E

AU - Sharma, Sweekriti

AU - Moynihan, Ray N

PY - 2021/6

Y1 - 2021/6

N2 - Innovations in technologies for early detection of diseases, such as breast cancer, dementia, and atrial fibrillation, are gaining increasing attention. The media is a key avenue through which tests are promoted to asymptomatic individuals, and it could have an important role in encouraging realistic expectations of the benefits and harms of early detection, including unnecessary diagnoses. Evidence suggests that medical media coverage tends to overplay benefits, downplay harms, and ignore conflicts of interest, but there are few data on coverage of early detection tests.

AB - Innovations in technologies for early detection of diseases, such as breast cancer, dementia, and atrial fibrillation, are gaining increasing attention. The media is a key avenue through which tests are promoted to asymptomatic individuals, and it could have an important role in encouraging realistic expectations of the benefits and harms of early detection, including unnecessary diagnoses. Evidence suggests that medical media coverage tends to overplay benefits, downplay harms, and ignore conflicts of interest, but there are few data on coverage of early detection tests.

UR - https://www.scopus.com/pages/publications/85103587752

U2 - 10.1001/jamainternmed.2021.0261

DO - 10.1001/jamainternmed.2021.0261

M3 - Letter

C2 - 33818597

SN - 2168-6106

VL - 181

SP - 865

EP - 867

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

IS - 6

M1 - 0261

ER -

Global Media Coverage of the Benefits and Harms of Early Detection Tests

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this